Amphiphile Particle Morphology Control via Thermal Processing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing non-lamellar amphiphile-based particles often result in broad particle size distributions and a significant proportion of contaminant lamellar vesicular particles, which can lead to instability and variability in pharmacokinetics and efficacy, especially for intravenous administration.

Innovation Solution

A method involving heating lamellar and non-lamellar particles to an elevated temperature followed by cooling, which can convert at least 50% of lamellar particles to a non-lamellar form, thereby narrowing the particle size distribution and improving stability, is employed.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to produce non-lamellar amphiphile-based particles, then particles can be formed, but the particle size distribution becomes broad and contaminant lamellar vesicular particles are generated

Engineering Contradiction:
Improveparticle size distributionVSAvoidpharmacokinetic stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent applies parameter changes by adjusting the ratio of water to amphiphile mixture (specifically using 1-10 volumes of water per volume of amphiphile mixture) and controlling the pH level to transform the particle morphology from lamellar to non-lamellar structures. This parameter optimization narrows the particle size distribution and eliminates contaminant lamellar vesicular particles, thereby improving both manufacturing precision and pharmacokinetic stability.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If lamellar particles are present in the dispersion, then the formulation can be prepared, but the stability and efficacy variability increases

Engineering Contradiction:
Improveformulation stabilityVSAvoidparticle morphology control
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent transforms lamellar particles into non-lamellar particles by changing key parameters including water-to-amphiphile ratio (1-10:1 volumes) and pH level adjustment. These parameter changes drive the morphological transformation that eliminates contaminant lamellar vesicular particles, simultaneously improving formulation stability and particle morphology control precision.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If non-lamellar particles are used for intravenous administration, then controlled release and loading capacity are enhanced, but particle size distribution must be narrowly controlled

Engineering Contradiction:
Improveloading capacityVSAvoidparticle size distribution control
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent achieves narrow particle size distribution control while maintaining high loading capacity by optimizing the water-to-amphiphile ratio (1-10:1 volumes) and pH parameters. These parameter changes promote the formation of monodisperse non-lamellar particles with consistent sizes, enabling both enhanced productivity through improved loading capacity and manufacturing precision through narrow size distribution.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a dispersion with a narrower, more stable particle size distribution and a higher proportion of non-lamellar particles, enhancing the controlled release and loading capacity of active agents, while maintaining stability over time.

Implementation Method 1

heating lamellar and non-lamellar particles to an elevated temperature followed by cooling, which can convert at least 50% of lamellar particles to a non-lamellar form

Methodology Applied
Scientific EffectPhase transition: Phase Change

Implementation Method 2

heating said particles to an elevated temperature followed by cooling

Methodology Applied
Scientific EffectCooling: Cooling

Data Source

PatentUS9522377B2Method for improving the properties of amphiphile particles
Publication Date: 2016.12.20 CAMURUS AB
  • US9522377B2 patent drawing
  • US9522377B2 patent drawing
  • US9522377B2 patent drawing

AI summary

The present invention provides a method for forming a dispersion comprising non-lamellar amphiphile particles having improved phase behavior, particle size distribution and/or storage stability, said method comprising forming a dispersion of lamellar and optionally non-lamellar particles comprising at least one structuring agent in a polar solvent, heating said particles to an elevated temperature, followed by cooling, wherein said heating is to a temperature and for a period sufficient to provide, after cooling, a measurable improvement in phase behavior, particle size distribution and/or storage stability.